Summary
Objective
Patients with atrial fibrillation (AF) have a risk of cerebral embolism. Echocardiographic parameters elevate this risk significantly. However, there is little knowledge about the long–term fate and the rate of clinically silent cerebral embolism under continued oral anticoagulation. The aims of our study were to assess prognosis of patients with AF and determine a high risk group with an increased risk of cerebral embolism under oral anticoagulation.
Methods
Consecutive patients with persistent or permanent AF and left atrial (LA) thrombi, dense spontaneous echo contrast (SEC) and/or reduced LA appendage peak emptying velocities (LAAv) were included in the study (N = 128). Patients with AF and without echocardiographic risk factors (N = 114) served as controls. All patients were examined with transesophageal echocardiography, cranial magnetic resonance imaging and clinically during a period of three years.
Results
During the three–year follow–up period 6 (5%) of the high risk patients had cerebral embolism with neurological deficits. 4 (3%) patients died due to embolic events and 17 (13%) patients had silent embolism as documented on MRI. In the control group 8 (7%) patients had embolic events (n = 1 clinically apparent and n = 7 silent embolism) documented on MRI, one was clinically apparent. Study patients with an event had more commonly previous thromboembolism (p < 0.0001).
Conclusions
Patients with peristent or permanent AF and LA thrombi, dense SEC or reduced LAAv have an explicitly increased risk of cerebral embolism (21%) despite oral anticoagulation. Previous thromboembolic event is another important predictor for an event.
Similar content being viewed by others
References
Agmon Y, Khandheria BK, Gentile F, Seward JB (1999) Echocardiographic assessment of the left atrial appendage. J Am Coll Cardiol 34:1867–1877
Asinger RW, Koehler J, Pearce LA, Zabalgoitia M, Blackshear JL, Fenster PE, Strauss R, Hess D, Pennock GD, Rothbart RM, Halperin JL (1999) Pathophysiologic correlates of thromboembolism in non-valvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr 12:1088–1096
Bernhardt P, Schmidt H, Hammerstingl C, Hackenbroch M, Sommer T, Lüderitz B, Omran H (2004) Fate of left atrial thrombi in patients with atrial fibrillation determined by transesophageal echocardiography and cerebral magnetic resonance imaging. Am J Cardiol 94:801–804
Bernhardt P, Schmidt H, Hammerstingl C, Lüderitz B, Omran H (2005) Patients with atrial fibrillation and dense spontaneous echo contrast at high risk – a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Coll Cardiol 45:1807–1812
Corrado G, Tadeo G, Beretta S, Tagliagambe LM, Manzillo GF, Spata M, Santarone M (1999) Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation. Chest 115:140–143
Fatkin D, Kelly RP, Feneley MP (1994) Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 23:961–969
Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC Jr, Klein WW, Alonso-Garcia A, Blomstrom- Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation); North American Society of Pacing and Electrophysiology (2001) ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 104:2118–2150
Goette A, Lendeckel U, Klein HU (2004) Molecular biology of the heart atrium. New insights into the pathophysiology of atrial fibrillation as well as its clinical implications. Z Kardiol 93:864–877
Goldman ME, Pearce LA, Hart RG, Zabalgoitia M, Asinger RW, Safford R, Halperin JL (1999) Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr 12:1080–1087
Henry WL, DeMaria A, Gramiak R, King DL, Kisslo JA, Popp RL, Sahn DJ, Schiller NB, Tajik A, Teichholz LE, Weyman AE (1980) Report of the american society of echocardiography committee on nomenclature and standards in two-dimensional echocardiography. Circulation 62:212–215
Jorg I, Harenberg J, Fenyvesi T, Gladish R (2005) Atrial fibrillation and thromboprophylaxis in elderly patients. Z Kardiol 94:87–94
Kamp O, Verhorst P, Welling R, Visser C (1999) Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation. Eur Heart J 20:979–985
Landwehr P, Schulte O, Voshage G (2001) Ultrasound examination of carotid and vertebral arteries. Eur Radiol 11:1521–1534
Laupacis A, Albers G, Dalen J, Dunn M, Jacobson A, Singer D (1998) Antithrombotic Therapy in Atrial Fibrillation. Chest 114:579S–589S
Leung D, Black I, Cranney G, Hopkins A, Walsh W (1994) Prognostic Implication of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol 24:755– 762
Leung DY, Davidson PM, Cranney GB, Walsh WF (1997) Thromboembolic risks of left atrial thrombus detected by transesophageal echocardiogram. Am J Cardiol 79:626–629
Moseley ME, Kucharczyk J, Mintorovitch J, Cohen Y, Kurhanewicz J, Derugin N, Asgari H, Norman D (1990) Diffusion-weighted MR imaging of acute stroke: correlation with T2- weighted and magnetic susceptibilityenhanced MR imaging in cats. Am J Neuroradiol 11:423–429
Omran H, Jung W, Rabahieh R, Schimpf R, Wolpert C, Hagendorff A, Fehske W, Luderitz B (1997) Left atrial chamber and appendage function after internal atrial defibrillation: a prospective and serial transesophageal echocardiographic study. J Am Coll Cardiol 29:131–138
Omran H, Jung W, Schimpf R, Mac- Carter D, Rabahieh R, Wolpert C, Illien S, Luderitz B (1998) Echocardiographic parameters for predicting maintenance of sinus rhythm after internal atrial defibrillation. Am J Cardiol 81:1446–1449
Omran H, Schmidt H, Hackenbroch M, Illien S, Bernhardt P, von der Recke G, Fimmers R, Flacke S, Layer G, Pohl C, Luederitz B, Schild H, Sommer T (2003) Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet 361:1241–1246
Stoddard MF, Singh P, Dawn B, Longaker RA (2003) Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J 145:676–682
Stollberger C, Chnupa P, Kronik G, Brainin M, Finsterer J, Schneider B, Slany J (1998) Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi. Ann Intern Med 128:630–638
Stroke Prevention in Atrial Fibrillation Investigators (1996) Adjusted dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 348:633–638
Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation (1998) The stroke prevention in atrial fibrillation investigators committee on echocardiography. Ann Intern Med 128:639–647
Zabalgoitia M, Halperin J, Pearce L, Blaskshear J, Asinger R, Hart R (1998) Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol 31:1622–1626
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bernhardt, P., Schmidt, H., Sommer, T. et al. Atrial fibrillation—. Clin Res Cardiol 95, 148–153 (2006). https://doi.org/10.1007/s00392-006-0344-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-006-0344-4